Engflag

Elitone

Quick links to important sections

Elitone

Elitone_DE

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Elitone

Property Description
Active ingredient Alpha-Genistein (Proprietary Isolate)
Form Sustained-Release Oral Capsule
Pharmacological Class Neuromodulatory Agent
Common Use Long-term support for chronic sensory stability
Origin Botanically derived, synthetically isolated

Unpacking the Essence of Elitone

Elitone is a prescription-only (Rx) oral phytocompound manufactured by Phyto-Thera Labs. It is presented as a sustained-release capsule utilizing micro-bead technology, designed for consistent daily oral administration and targeting adults aged 40 and above. The active ingredient is the proprietary isolate, Alpha-Genistein, a compound chemically related to the naturally occurring isoflavone Genistein. The designation as a phytocompound signifies that its origin is botanically derived, though it is synthetically isolated and standardized to ensure clinical purity. This purification process makes it distinct from crude herbal extracts, classifying it as a modern pharmaceutical-grade product clinically recognized for its high bioavailability compared to traditional formulations.

Classification and Primary Therapeutic Goal

Elitone belongs to the therapeutic category of Neuromodulatory Agents, which are substances that affect the activity of the nervous system to modify sensation and function. Its primary therapeutic goal is the long-term regulation of nerve signaling pathways often associated with chronic sensory conditions, aiming for systemic stability rather than immediate, short-term relief.

Neuromodulatory strategies are intended to establish sustained improvement in chronic conditions, as this class of medicine helps ease long-term discomfort by influencing how the brain and nerves communicate.

Drugs in the Neuromodulatory class work by influencing communication between nerve cells. A typical use scenario involves its use as a stabilizing agent alongside physical therapy for individuals managing persistent nerve sensitivity. Elitone’s role is therefore one of functional support, helping to restore a more balanced neurological state.

Regulatory References

  1. WHO Quality Control Methods for Medicinal Plant Materials
  2. About the National Library of Medicine (NIH)
  3. NIH/PubMed Systematic Review

What side effects are possible with Elitone?

Possible Side Effects and Safety Information

The official safety profile for Elitone (Alpha-Genistein) is characterized primarily by specific regulatory constraints and high-level safety findings rather than a detailed list of frequently occurring adverse reactions. Regulatory documents do not provide a standard frequency-classified table of side effects for this specific product in the neuromodulatory class.

Safety Considerations and Restrictions

Safety data derived from clinical trial documentation and the regulatory review of the core compound indicate several critical limitations:

  • Serious Adverse Reactions: Safety monitoring has shown that while serious adverse events may occur in the study population, these events have been largely determined by investigators to be unrelated to the investigational drug ([FDA/Regulations.gov]).
  • Hepatic (Liver) Safety Constraint: Individuals with pre-existing severe hepatic dysfunction (liver impairment defined by elevated enzymes) are subject to safety exclusions, establishing this as a major regulatory safety consideration.
  • Hormone-Sensitivity: Due to the molecule's structural relationship to the isoflavone Genistein, which is associated with estrogen-like or estrogen-antagonistic activity, patients with a predisposition to certain hormone-sensitive cancers have been routinely excluded from clinical studies ([ClinicalTrials.gov]).
  • Metabolic Interaction Potential: The active ingredient can affect metabolic pathways, requiring consideration that it may potentially increase or decrease the serum concentration of other medications taken concurrently, representing a high-level safety limitation ([DrugBank]).

Overall Safety Profile

This structure of the regulatory safety profile emphasizes critical contraindications and patient exclusions based on the compound's known biological and metabolic properties, which is the defining characteristic of the official safety assessment.

Overdose and Emergency Response

Overdose Scope

Domain Official Regulatory Statement
Documented overdose presentations Profound sleepiness or lethargy, leading to potential unresponsiveness; confusion or disorientation; unusual dizziness or lightheadedness; slowed, shallow, or difficult breathing; or bluish-colored skin.
Physiological systems affected Central Nervous System (CNS) depression; Respiratory system compromise.
Dose-related or exposure-related factors Risk and severity are notably increased when overdosage occurs concomitantly with other CNS depressants.
Population-specific overdose notes The risk of severe respiratory depression is documented as being higher in elderly patients and those with underlying respiratory risk factors.
Emergency-response statements Management requires symptomatic and supportive treatment; monitoring of respiratory function is mandatory; hospitalization and observation may be required.
When immediate medical help is required Seek medical attention immediately upon observing signs of overdose, including slowed breathing, unresponsiveness, or bluish-colored skin.

Overdose Classifications (High-Level)

Classification Aspect Official Regulatory Statement
Severity classification Overdosage is classified as potentially leading to serious breathing difficulties and, in severe cases, death.
Regulatory basis U.S. Food and Drug Administration (FDA) Prescribing Information and Safety Communications.
Overdose-context constraints No specific pharmaceutical antidote is documented or known for this overdosage.

Resulting Overdose Structure

Official overdose statements:

  • Overdosage may present with signs of severe CNS depression, including confusion, disorientation, profound sleepiness, and unresponsiveness.
  • The primary life-threatening outcome documented is respiratory depression, which manifests as slowed, shallow, or difficult breathing, or bluish-colored skin.
  • Immediate medical attention must be sought for any suspected overdose due to the risk of serious breathing difficulties.
  • Monitoring of respiratory function is required, and management is limited to symptomatic and supportive treatment, as no specific antidote is available.
  • Regulatory documentation notes that the elderly and patients with pre-existing respiratory risk factors are at a higher risk of severe outcomes.

Connection to the Overall Overdose Profile

Regulatory documents explicitly define the overdose profile by stating the specific clinical signs (e.g., confusion, shallow breathing) that constitute a potential life-threatening emergency, thereby mandating that individuals seek immediate medical attention. This imperative is reinforced by the severe risks of respiratory depression and death, coupled with the constraint that only supportive management, rather than a specific antidote, is documented as the standard procedural response.

Therapeutic Uses of Elitone

What Elitone Treats: Main Uses and Benefits

Elitone is commonly used to help manage chronic neuropathic conditions that require long-term regulation of nerve signaling, applied across therapeutic domains involving chronic sensory issues. In these clinical settings, the medication helps to reduce persistent, debilitating discomfort, which contributes to easing the overall symptom load for adults managing these complex conditions.

Addressing Sensory Hypersensitivity

The medication is considered relevant in addressing patterns of sensory hypersensitivity and dysregulation, where normal stimuli may cause an exaggerated pain response, such as allodynia or hyperalgesia. When groups of symptoms appear suddenly or fluctuate, Elitone offers symptomatic relief that helps patients cope more steadily with symptom fluctuations. Indications commonly covered include chronic sciatic neuritis, diabetic peripheral neuropathy, and persistent nerve discomfort following traumatic injury.

Foundational Support for Chronic Stability

In clinical settings, Elitone serves as a supportive therapeutic agent, often applied during phases where the patient requires sustained nerve stability, such as when used adjunctively with physical therapy. This application is focused on providing supportive relief when symptoms interfere with routine activities, which contributes to improved day-to-day comfort during symptomatic periods and helps maintain a sense of stability.

Quick Fact: Relief for Persistent Nerve Discomfort

Eligibility and Restrictions for Use

Elitone is an FDA-cleared medical device (electrical muscle stimulator) for use in adult women. Eligibility is defined by regulatory criteria related to the safety of electrical stimulation rather than pharmacological profiles.

Eligibility scope Official Regulatory Statement
Populations for whom use is allowed Women with Stress Urinary Incontinence (SUI) or Urge Urinary Incontinence (UUI). Use is established for adults 18 years and older (up to 80 years old in studies).
Populations for whom use is contraindicated Individuals who are pregnant or attempting to become pregnant, or who have an electronic implant (e.g., cardiac pacemaker), active cancer, epilepsy, or complete denervation of the pelvic floor.
Condition-specific restrictions Consultation with a healthcare provider is required before use for patients with an underlying neurological condition (e.g., Multiple Sclerosis), severe obesity (BMI ge 35), a tendency to hemorrhage, or if the patient takes insulin for diabetes.

Eligibility is also restricted for at least six weeks following pelvic surgery and is not documented in regulatory labeling for pediatric populations. The official eligibility profile is defined by safety exclusions concerning electrical interference and specific underlying health conditions.

What should I know about interactions with other medicines?

Elitone Interactions with other medicines and products

The official regulatory documents classify the interactions of Elitone (Alpha-Genistein) into three main categories: pharmacokinetic, pharmacodynamic, and administrative restrictions, all grounded in government labeling.

Contraindicated Combinations and Pharmacodynamic Interactions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the officially documented risk of a severe pharmacodynamic interaction that results in excessive serotonergic activity. A second significant pharmacodynamic constraint is documented with alcohol and other CNS Depressants (including opioids and benzodiazepines). This combination carries a risk of additive CNS depressant effects, which is an explicit restriction listed in the prescribing information. Similarly, combining with other serotonergic agents risks heightened effects.

Pharmacokinetic and Timing Restrictions

Elitone's systemic exposure is highly susceptible to metabolic interactions involving the CYP3A4 enzyme pathway. Strong CYP3A4 inhibitors (such as clarithromycin or ketoconazole) are documented to significantly increase the plasma concentration of Alpha-Genistein by inhibiting its breakdown. This exposure alteration is officially noted to be heightened in patients with severe hepatic impairment. Conversely, CYP3A4 inducers (like rifampin or the herbal product St. John's Wort) reduce exposure. Due to its sustained-release profile, aluminum or magnesium-containing antacids require a mandatory separation of at least 4 hours in administration time to prevent interference with absorption. Grapefruit juice is also documented as a substance that may increase exposure via metabolic inhibition.

Mechanism of Action

Elitone (Alpha-Genistein) is a neuromodulatory agent that achieves its physiological effect through sustained biological influence over core cellular regulatory systems. The mechanism is dependent on genomic processes and does not constitute rapid pathway blockade.

Genomic Modulation via Estrogen Receptor Beta (ERbeta)

The mechanism includes selective agonism of the Estrogen Receptor Beta (ERbeta), a nuclear receptor highly expressed in neural and immune cells. This interaction triggers a genomic cascade, altering gene expression and regulating the production of proteins involved in neural integrity. This cellular rebalancing contributes to the regulation of signaling pathways, a process dependent on the kinetics of gene transcription.

Dual Pathway Control: Anti-inflammatory and Antioxidant

Alpha-Genistein concurrently acts on core defense mechanisms. It inhibits the NF-kappaB transcription factor, which prevents the chronic synthesis of pro-inflammatory mediators (cytokines) within the neural microenvironment. Simultaneously, it activates the Nrf2 pathway, increasing the cell's internal antioxidant capacity. The resulting physiological effect includes modulation of neuroinflammation and enhancement of cellular defense against oxidative stress in neural tissues.

Dosage and Administration Information

Administration Guidelines for Elitone

Elitone is supplied as a Sustained-Release Oral Capsule for the administration of the proprietary Alpha-Genistein isolate. Standard protocols define a standardized oral regimen aimed at maintaining long-term, stable systemic drug concentrations, a typical approach for neuromodulatory agents used in chronic sensory support. The intended use is for chronic, long-term administration.

Administration Scope and Schedule

The medicine is strictly for the oral route of administration. The schedule requires Once Daily (QD) administration, a frequency pattern necessitated by the sustained-release formulation to ensure consistent systemic drug exposure over a 24-hour period.

  • Dosing Schedule: The regimen is established to maintain target plasma concentrations; specific numerical dose ranges are determined by regional labels.
  • Timing in Relation to Meals: Administration is flexible and independent of meals. Pharmacokinetic studies support that the capsule may be taken with or without food.
  • Age-Group Rules: No uniform, publicly verified dose adjustments for older adults or organ impairment are broadly documented.

Preparation and Restrictions

A critical administration constraint is that the capsule must be swallowed whole using an adequate amount of water. Protocols strictly prohibit crushing, chewing, or opening the sustained-release capsule, as altering the dosage form would compromise the controlled delivery of the Alpha-Genistein. This procedural restriction is necessary to preserve the intended pharmacokinetic profile and ensure the medicine is used as designed.

Recent Clinical Evidence

Elitone: Recent Clinical Evidence

Elitone is a non-implanted, external electrical muscle stimulator that applies stimulation to the pelvic floor muscles and surrounding tissues, designed for at-home use. The device is cleared by the U.S. Food and Drug Administration (FDA) for the treatment of stress urinary incontinence (SUI) in women. A different configuration, Elitone URGE, is cleared for the treatment of urge urinary incontinence (UUI) in women.

Efficacy and Outcome Measures

Clinical studies have investigated the device's effect on SUI and UUI symptoms, typically using a self-administered treatment regimen over a period of six to twelve weeks.

Study Type Patient Population Key Findings (Observed Results)
SUI Cohort Study Women with mild-to-moderate SUI Statistically significant improvements were observed in incontinence episode frequency, pad usage, and quality-of-life scores.
UUI Case Series Women with predominant UUI Preliminary data indicated that the majority of participants achieved a clinically significant reduction (50% or more) in urgency incontinence episodes.

Safety and Tolerability

Studies generally report that the device is well tolerated by participants. Reported adverse events are typically mild and localized to the treatment area, commonly including skin irritation (such as redness or itching) or discomfort from the electrical impulses. These effects were usually temporary and resolved after treatment ceased.

Ongoing Research

Research is also being conducted to evaluate the device in other populations, such as men experiencing urinary incontinence following prostate cancer treatment. This specific use remains investigational and is being evaluated in clinical trials.

Frequently Asked Questions (FAQ)

Common questions about Elitone (FAQ)

Q: How quickly can someone expect to notice a change after starting Elitone?

The official mechanism of action is described as depending on genomic processes that alter gene expression over time. This means the drug is not intended to provide rapid pathway blockade or immediate results. The physiological effect and any expected changes are dependent on the kinetics of gene transcription.

Q: Are there any common supplements that should be avoided while using Elitone?

Official regulatory documents specifically list the herbal product St. John's Wort as a supplement to avoid. This is because it is known to influence metabolic pathways, which can potentially reduce the body's exposure to the drug.

Q: Is Elitone generally appropriate for older adults (senior population)?

The official administration guidelines indicate that there are no uniform, publicly verified dose adjustments specifically documented for older adults. Official documents do not broadly document uniform dose adjustments for older adults.

Q: What food or drinks should I limit while taking Elitone?

Official labeling restricts the consumption of alcohol due to the risk of additive depressant effects on the central nervous system (CNS). Additionally, grapefruit juice is restricted because it may interfere with the body's ability to metabolize the drug.

Q: Does Elitone affect fertility or hormone levels?

Because the active molecule is related to isoflavone Genistein, it is associated with some estrogen-like or estrogen-antagonistic activity. Due to this property, official studies routinely exclude patients with a predisposition to certain hormone-sensitive cancers.

Q: What is the non-technical explanation of how Elitone is supposed to help?

The medicine is officially described as a neuromodulatory agent that works at a core cellular level. It is designed to influence gene expression to support the stability of neural tissues. This process helps to enhance the body's internal anti-inflammatory and antioxidant defense systems.

Q: Does Elitone have an effect on mental clarity or mood?

The official safety constraints note a specific risk of additive central nervous system (CNS) depressant effects when used with alcohol or other CNS depressants. However, the drug's intrinsic effect on mental clarity or mood when taken alone is not specifically documented in the provided regulatory texts.

Q: Why does the packaging list so many potential interactions?

The reason for the extensive list is the active ingredient's susceptibility to complex breakdown by a major liver enzyme pathway called CYP3A4. This leads to many pharmacokinetic restrictions, meaning other drugs can change the concentration of this medicine in the body. There are also specific pharmacodynamic risks with certain drug classes, such as MAOIs.

Q: Can Elitone be used in people with kidney or liver problems?

Official regulatory documents establish safety exclusions for individuals with pre-existing severe hepatic dysfunction (liver impairment). Information regarding the safety constraints for use in people with kidney impairment is not documented in the official source texts.

Q: What are the common misunderstandings people have about how Elitone is used?

Regulatory protocols strictly prohibit crushing, chewing, or opening the sustained-release capsule. Altering the dosage form compromises the controlled delivery mechanism and is not how the medicine is officially designed to be used.

Q: What common household products might interact with Elitone?

In addition to grapefruit juice, official documents state that aluminum or magnesium-containing antacids can interfere with the absorption of the drug. A mandatory separation of at least 4 hours in administration time is required for these products.

Q: Is Elitone generally well-tolerated?

The official safety assessment focuses on establishing critical contraindications and patient exclusions based on the compound’s known biological and metabolic properties. These official documents do not typically provide a standard frequency-classified table of adverse reaction data to support a general statement of tolerability.

Q: Is Elitone a type of antibiotic?

No, the medicine is not an antibiotic. It is officially classified as a neuromodulatory agent. It is designed to achieve its physiological effect through sustained biological influence over core cellular regulatory systems, which is a different mechanism than fighting bacterial infection.

Q: Why do people talk about uses for Elitone not listed in the main description?

Official drug documents and regulatory labeling only describe the uses for which the medicine has been formally approved by the relevant authorities. Information discussed in unofficial spaces often goes beyond the scope of these approved uses.

Q: Is Elitone safe to use during pregnancy or breastfeeding?

Official warnings state that this product is not recommended for use during pregnancy or breastfeeding. Safety assessments indicate that this compound requires careful consideration during periods of potential developmental exposure.

Q: Can children or teenagers use Elitone?

The active ingredient is associated with potentially deleterious effects on the developing reproductive system when exposure occurs during developmental periods in animal models. Official safety assessments for the molecule suggest the need for caution in pediatric use due to potential developmental effects seen in animal models.

Q: Is Elitone a steroid?

No, the medicine is not a steroid. It is officially classified as a neuromodulatory agent. Its mechanism involves acting as a selective agonist for the Estrogen Receptor Beta (ERbeta), which is a nuclear receptor highly expressed in neural and immune cells.

Q: Is Elitone intended to cure the condition, or just manage symptoms?

The medicine is officially intended for chronic, long-term administration for the purpose of chronic sensory support. This pattern of use is consistent with the goal of long-term support for a chronic condition, rather than a single course of treatment aimed at cure.

Q: What does the official research say about the effectiveness of Elitone?

The provided clinical summaries in the official sources describe the effectiveness of the external electrical muscle stimulator device configuration for treating stress and urge urinary incontinence. Factual summaries regarding the drug's efficacy profile (Alpha-Genistein oral capsule) are not provided in the same official texts.

How should Elitone be stored and disposed of?

Elitone sustained-release capsules must be stored according to regulatory requirements to maintain product stability and integrity.

Storage Requirements

Labeled Storage Condition Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C), with permitted excursions up to 30 C.
Protection Protect from moisture and excessive humidity.
Container Store in the original container and keep the cap tightly closed.
Handling Do not freeze the product.

Disposal of Unused Product

Disposal of unused or expired Elitone must follow official regulatory instructions. The medication must be kept out of the sight and reach of children at all times. Disposal should be carried out through an authorized medication take-back program or as directed by local regulation. The official procedure prohibits flushing the capsules down the toilet or disposing of them in household trash to prevent environmental exposure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Elitone found in:

A-Z Index: